Document Detail


New aspects on etiology, biochemistry, and therapy of portal systemic encephalopathy: a critical survey.
MedLine Citation:
PMID:  9263239     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is scientific agreement that portal systemic encephalopathy (PSE) is caused morphologically by portal systemic shunts and biochemically by constituents of the portal venous blood. Ammonium has a key role in the pathogenesis of PSE. Direct correlations with the degree of PSE have been established exclusively with glutamine, i.e. the terminal product of the peripheral detoxification of ammonium. In PSE, ammonium is probably responsible for damage to astrocytic and neuronal cells. Ammonium's toxic effect is due to the intracerebral glutamine synthesis. After several metabolic steps, which will be discussed in detail, brain cell damage is caused directly or indirectly (exitotoxically) by energy deficiency. Hyperammonemia and PSE are each well defined though different forms of disturbance. Therefore, ammonium is not the sole decisive factor in the pathogenesis of PSE. We performed a detailed and critical analysis of all studies on amino acid therapy of PSE, especially those that were randomized and controlled. This analysis revealed a close and direct correlation between qualitative and quantitative dosages of amino acids on one hand, and parallel improvements of amino acid imbalance (essentially associated with PSE) and degree of PSE on the other. A close and direct dose/efficacy correlation must be assumed. Disturbed plasmatic amino acid homeostasis and cerebral monoaminergic neurotransmission are probably important pathogenic factors of PSE. A fundamental cofactor in the efficacy of each adequate amino acid therapy might be a substantial decrease of endogenous ammonium production. Physiologic benzodiazepines may also have an important function in the pathogenesis of PSE: not so, however, the glutamate-ergic and GABA-ergic neurotransmission, which are disturbed principally in PSE. In close correlation to pathogenesis, established and proposed therapies of PSE are critically discussed.
Authors:
P Jürgens
Related Documents :
1657429 - Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, ...
2442679 - Decreased glutamic acid and increased 5-hydroxytryptamine in huntington's disease brain.
113249 - Changes in free amino acid level due to physical and chemical agents in ageing drosophila.
21475879 - The bone anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin antagonize nf...
21875709 - Immobilization of uricase in langmuir and langmuir-blodgett films of fatty acids and a ...
839439 - Application of principles of steady-state kinetics to the estimation of gamma-aminobuty...
12957159 - Transformation of phthalates in young landfill cells.
4088129 - Prevalence of gemella haemolysans on the pharyngeal mucosa of man.
21442459 - Rapid onset and sustained efficacy (rose) study: results of a randomised, multicentre t...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Nutrition (Burbank, Los Angeles County, Calif.)     Volume:  13     ISSN:  0899-9007     ISO Abbreviation:  Nutrition     Publication Date:  1997 Jun 
Date Detail:
Created Date:  1997-10-30     Completed Date:  1997-10-30     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  8802712     Medline TA:  Nutrition     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  560-70     Citation Subset:  IM    
Affiliation:
Medical Department, St. Georg Hospital, Hamburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acids / therapeutic use
Animals
Glutamine / metabolism
Hepatic Encephalopathy / chemically induced*,  metabolism,  therapy*
Humans
Quaternary Ammonium Compounds / blood,  toxicity
Chemical
Reg. No./Substance:
0/Amino Acids; 0/Quaternary Ammonium Compounds; 56-85-9/Glutamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Venocutaneous fistula: a central venous catheter--associated complication.
Next Document:  Influence of liver failure, ascites, and energy expenditure on the response to oral nutrition in alc...